6533b822fe1ef96bd127cef1
RESEARCH PRODUCT
Lipoproteins in atherosclerosis process
Mario DaidoneAntonino TuttolomondoValentina ArnaoAntonio Pintosubject
0301 basic medicineFunctional featuresLipoproteinsAtherogenisiDysfunctional family030204 cardiovascular system & hematologyBioinformaticsBiochemistryOxidised03 medical and health sciences0302 clinical medicineDrug DiscoveryAnimalsHumansMedicineHDL-CRisk factorLipoproteinPharmacologybusiness.industryAnimalOrganic ChemistryAtherosclerotic diseaseAtherosclerosismedicine.diseaseClinical Practice030104 developmental biologyDyslipidemiaAtherosclerosiMolecular Medicinelipids (amino acids peptides and proteins)DysfunctionalbusinessDyslipidemiaHumandescription
Background:Dyslipidaemias is a recognized risk factor for atherosclerosis, however, new evidence brought to light by trials investigating therapies to enhance HDLcholesterol have suggested an increased atherosclerotic risk when HDL-C is high.Results:Several studies highlight the central role in atherosclerotic disease of dysfunctional lipoproteins; oxidised LDL-cholesterol is an important feature, according to “oxidation hypothesis”, of atherosclerotic lesion, however, there is today a growing interest for dysfunctional HDL-cholesterol. The target of our paper is to review the functions of modified and dysfunctional lipoproteins in atherogenesis.Conclusion:Taking into account the central role recognized to dysfunctional lipoproteins, measurements of functional features of lipoproteins, instead of conventional routine serum evaluation of lipoproteins, could offer a valid contribution in experimental studies as in clinical practice to stratify atherosclerotic risk
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2019-05-21 |